Five numbers in the abstract
Where each one falls
Where it lands on the map
What it changes
Among 23 other studies
the abstract, start to end
… period with vildagliptin vs placebo by -1.0 mmol/L (P = .018), and there …
Mean HbA1c changed by -0.5 ± 0.1% (P < .0001) from a baseline of …
… fasting triglyceride decreased by 0.2 ± 0.1 mmol/L from a baseline of 1.5 ± …
… fasting plasma glucose changed by -0.9 ± 0.3 mmol/L (P = .001) in the …
… 1.6 ± 0.5 kg from a baseline of 82.6 ± 3.4 kg (P = .002) in the …
← favours treatmentfavours comparator →
could be chanceNo interval given · direction only, strength unknown
Glycemic control
−1.0
Glycemic control
0.1
Lipids
−0.10
Glycemic control
0.3
Body weight & composition
−3.40
DPP-4 inhibitorsGlycemic controlBody weight & compositionLipids
DPP-4 inhibitors × glycemic controlhelps?replicated
unlikelylikely
0.820.84 without it
DPP-4 inhibitors × body weight & compositionhelps?mixed
unlikelylikely
0.500.43 without it
← favours treatmentfavours comparator →
1 / 5